CN114076266B - Light source module capable of improving immunity of human body and lighting device - Google Patents

Light source module capable of improving immunity of human body and lighting device Download PDF

Info

Publication number
CN114076266B
CN114076266B CN202010843806.2A CN202010843806A CN114076266B CN 114076266 B CN114076266 B CN 114076266B CN 202010843806 A CN202010843806 A CN 202010843806A CN 114076266 B CN114076266 B CN 114076266B
Authority
CN
China
Prior art keywords
light source
lemon
group
lamp
infrared
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN202010843806.2A
Other languages
Chinese (zh)
Other versions
CN114076266A (en
Inventor
吴育林
梁明
郭海浪
郑书武
何志鹏
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Guangdong Cosio Lighting Co Ltd
Original Assignee
Guangdong Cosio Lighting Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Guangdong Cosio Lighting Co Ltd filed Critical Guangdong Cosio Lighting Co Ltd
Priority to CN202010843806.2A priority Critical patent/CN114076266B/en
Publication of CN114076266A publication Critical patent/CN114076266A/en
Application granted granted Critical
Publication of CN114076266B publication Critical patent/CN114076266B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • FMECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F21LIGHTING
    • F21SNON-PORTABLE LIGHTING DEVICES; SYSTEMS THEREOF; VEHICLE LIGHTING DEVICES SPECIALLY ADAPTED FOR VEHICLE EXTERIORS
    • F21S2/00Systems of lighting devices, not provided for in main groups F21S4/00 - F21S10/00 or F21S19/00, e.g. of modular construction
    • FMECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F21LIGHTING
    • F21VFUNCTIONAL FEATURES OR DETAILS OF LIGHTING DEVICES OR SYSTEMS THEREOF; STRUCTURAL COMBINATIONS OF LIGHTING DEVICES WITH OTHER ARTICLES, NOT OTHERWISE PROVIDED FOR
    • F21V19/00Fastening of light sources or lamp holders
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02BCLIMATE CHANGE MITIGATION TECHNOLOGIES RELATED TO BUILDINGS, e.g. HOUSING, HOUSE APPLIANCES OR RELATED END-USER APPLICATIONS
    • Y02B20/00Energy efficient lighting technologies, e.g. halogen lamps or gas discharge lamps
    • Y02B20/40Control techniques providing energy savings, e.g. smart controller or presence detection

Landscapes

  • Engineering & Computer Science (AREA)
  • General Engineering & Computer Science (AREA)
  • Cultivation Of Plants (AREA)

Abstract

The invention relates to the technical field of lighting equipment, in particular to a light source module capable of improving human immunity and a lighting device, comprising a substrate and a light source arranged on a clamping plate, wherein the light source comprises a lemon light source, a red light source and an infrared light source; the wavelength of light rays emitted by the lemon light source is 567-587 nm, and the spectral power of the lemon light source accounts for 30-35% of the total power of the light source; the wavelength of the light emitted by the red light source is 620 nm-700 nm, and the spectral power of the red light source accounts for 30-35% of the total power of the light source; the wavelength of light rays emitted by the infrared light source is 760 nm-1 mm, and the spectral power of the infrared light source accounts for 30-35% of the total power of the light source. The light source module can enhance the phagocytosis rate and phagocytosis index of macrophages and improve the immunity of organisms (including human bodies) by being provided with the lemon light source, the red light source and the infrared light source.

Description

Light source module capable of improving immunity of human body and lighting device
Technical Field
The invention relates to the technical field of lighting equipment, in particular to a light source module capable of improving human immunity and a lighting device.
Background
Immunity is the body's own defense mechanism, which is the body's ability to recognize and eliminate any foreign bodies (viruses, bacteria, etc.) that invade, treat aging, injury, death, degenerated own cells, and recognize and treat mutant cells and virus-infected cells in the body. The low immunity is easy to cause bacterial, virus, fungus and other infections, so the most direct manifestation of the low immunity is illness. The immune system of the human body has the following responsibilities: the population is protected from outside organisms (including bacterial viruses) and traitored cells, such as cancer cells, are suppressed from the inside. The immune system includes immune organs, immune cells and immunologically active substances; through the immune cells (including neutrophils and natural killer cells) of all organs which are patrol in the human body around the clock, pathogenic microorganisms can be killed at any time, so that the aim of improving the immunity is fulfilled.
Existing methods for improving immunity generally include immunization, balanced diet, maintenance of good hygiene habits, multiple physical exercises, and the like. People can be in the illumination of the lamp for a long time in life and work, so that the immunity is improved by the illumination method of the lamp, and the trouble of purposely removing the immunization for vaccination can be saved.
Disclosure of Invention
The invention aims to provide a light source module and a lighting device capable of improving human immunity, and aims to solve the technical problem that people in the prior art need to specially perform immunization and vaccination for improving the immunity.
In order to achieve the above-mentioned purpose, the present invention proposes a light source module capable of improving immunity of human body, comprising a substrate and a light source arranged on the splint, wherein the light source comprises a lemon light source, a red light source and an infrared light source;
the wavelength of light rays emitted by the lemon light source is 567-587 nm, and the spectral power of the lemon light source accounts for 30-35% of the total power of the light source;
the wavelength of the light emitted by the red light source is 620 nm-700 nm, and the spectral power of the red light source accounts for 30-35% of the total power of the light source;
the wavelength of light rays emitted by the infrared light source is 760 nm-1 mm, and the spectral power of the infrared light source accounts for 30-35% of the total power of the light source.
Preferably, the wavelength of the light emitted by the infrared light source is 760 nm-14000 nm.
Preferably, the light source further comprises an ultraviolet light source, and the wavelength of light emitted by the ultraviolet light source is 315 nm-400 nm.
Preferably, the spectral power of the ultraviolet light source accounts for 2-6% of the total power of the light source.
Preferably, the spectral power of the lemon light source, the red light source and the infrared light source respectively account for 32% of the total power of the light sources, and the spectral power of the ultraviolet light source accounts for 4% of the total power of the light sources.
Preferably, the illuminance E of the light source is 200LX to 600LX.
Preferably, the lemon light source, the red light source, the infrared light source and the ultraviolet light source are respectively and uniformly distributed around the center of the substrate;
the lemon light source and the ultraviolet light source are arranged at intervals, and the red light source and the infrared light source are arranged at intervals.
Preferably, the substrate is circular, and the plurality of lemon light sources are uniformly distributed along the same diameter direction of the substrate; the plurality of red light sources are uniformly distributed along the same diameter direction of the substrate; the plurality of infrared light sources are uniformly distributed along the same diameter direction of the substrate; the plurality of ultraviolet light sources are uniformly distributed along the same diameter direction of the substrate.
On the other hand, the invention also provides a lighting device capable of improving human immunity, which comprises a lamp main body and any one of the light source modules, wherein the light source module is arranged in the lamp main body.
Preferably, the lamp body comprises a first radiator and a first lampshade, the first radiator and the first lampshade are packaged to form a lamp cavity, the light source module is mounted on the first radiator, and the light source module is located inside the lamp cavity.
The light source module and the lighting device capable of improving the immunity of a human body have the following beneficial effects:
1. the light source module can enhance the phagocytosis rate and phagocytosis index of macrophages and improve the immunity of organisms (including human bodies) by being provided with the lemon light source, the red light source and the infrared light source.
1. The light source comprises an ultraviolet light source, so that the light source module has better effect of improving the immunity of organisms (including human bodies).
2. When the spectral power of the lemon light source, the red light source and the infrared light source respectively account for 32% of the total power of the light source and the spectral power of the ultraviolet light source accounts for 4% of the total power of the light source, the light source module has better effect on improving organism immunity.
3. In order to improve the effect of improving the organism immunity of the light source module, the illumination range of the light source is kept in the range of 200 LX-600 LX.
Drawings
In order to more clearly illustrate the embodiments of the present invention or the technical solutions in the prior art, the drawings that are required in the embodiments or the description of the prior art will be briefly described, and it is obvious that the drawings in the following description are only some embodiments of the present invention, and other drawings may be obtained according to the structures shown in these drawings without inventive effort for a person skilled in the art.
FIG. 1 is a schematic diagram of a light source module according to the present invention;
fig. 2 is a schematic structural diagram of a lighting device according to a second embodiment of the present invention;
FIG. 3 is a schematic diagram of an explosion structure of a lighting device according to a second embodiment of the present invention;
fig. 4 is a schematic side view of a first heat sink of a second embodiment of the lighting device;
fig. 5 is a schematic axial structure of a first heat sink of a second embodiment of the lighting device of the present invention;
fig. 6 is a schematic axial side structure of a first lampshade of a lighting device according to a second embodiment of the invention;
FIG. 7 is a schematic cross-sectional view of an axial side structure of a third embodiment of the lighting device of the present invention;
FIG. 8 is an isometric view of a third embodiment of a lighting device of the present invention;
FIG. 9 is a schematic cross-sectional view of a fourth embodiment of the lighting device of the present invention;
fig. 10 is a schematic axial side structure of a lighting device according to a fourth embodiment of the present invention.
Reference numerals illustrate:
Figure GDA0004171556700000031
Figure GDA0004171556700000041
the achievement of the objects, functional features and advantages of the present invention will be further described with reference to the accompanying drawings, in conjunction with the embodiments.
Detailed Description
The following description of the embodiments of the present invention will be made clearly and fully with reference to the accompanying drawings, in which it is evident that the embodiments described are only some, but not all embodiments of the invention. All other embodiments, which can be made by those skilled in the art based on the embodiments of the invention without making any inventive effort, are intended to be within the scope of the invention.
It should be noted that, if directional indications (such as up, down, left, right, front, and rear … …) are included in the embodiments of the present invention, the directional indications are merely used to explain the relative positional relationship, movement conditions, etc. between the components in a specific posture (as shown in the drawings), and if the specific posture is changed, the directional indications are correspondingly changed.
In addition, if there is a description of "first", "second", etc. in the embodiments of the present invention, the description of "first", "second", etc. is for descriptive purposes only and is not to be construed as indicating or implying a relative importance or implicitly indicating the number of technical features indicated. Thus, a feature defining "a first" or "a second" may explicitly or implicitly include at least one such feature. In addition, the technical solutions of the embodiments may be combined with each other, but it is necessary to base that the technical solutions can be realized by those skilled in the art, and when the technical solutions are contradictory or cannot be realized, the combination of the technical solutions should be considered to be absent and not within the scope of protection claimed in the present invention.
Example 1
As shown in fig. 1, a light source module capable of improving immunity of human body comprises a substrate 11 and a light source 12 arranged on the substrate 11, wherein the light source 12 comprises a lemon light source 121, a red light source 122 and an infrared light source 123;
the wavelength of the light emitted by the lemon light source 121 is 567-587 nm, and the spectral power of the lemon light source 121 accounts for 30-35% of the total power of the light source 12;
the wavelength of the light emitted by the red light source 122 is 620 nm-700 nm, and the spectral power of the red light source 122 accounts for 30-35% of the total power of the light source 12;
the wavelength of the light emitted by the infrared light source 123 is 760 nm-1 mm, and the spectral power of the infrared light source 123 accounts for 30-35% of the total power of the light source 12.
The lemon light source 121 is used for emitting lemon light with a wavelength of 67nm to 587nm, the red light source 122 is used for emitting red light with a wavelength of 620nm to 700nm, the infrared light source 123 is used for emitting infrared light with a wavelength of 760nm to 1mm (1 mm=1000000nm), and the lemon light source 121, the red light source 122 and the infrared light source 123 are mixed to form specific light. Wherein the lemon light source 121, the red light source 122 and the infrared light source 123 all account for 30-35% of the total power of the light source 12. Lemon color can improve nutrient absorption and build bone. The red light energy stimulates the sensory nervous system, constructs and stimulates the liver, accelerates the skin toxin expelling metabolism; facilitating drainage of debris (such as residual tissue) through the skin. The infrared rays can improve immunity, enhance disease resistance and facilitate skin smoothness. Spectral power is an abbreviation for spectral power distribution (spectral power distribution); when the spectral density of a wave is multiplied by an appropriate coefficient, the power carried per unit frequency wave will be obtained, which is referred to as the power spectral density (power spectral density, PSD) or spectral power distribution (spectral power distribution, SPD) of the signal.
In the process of creation of the invention, the inventor performs a first group of experiments by using mice, wherein the experimental objects are 40 mice with the weight of about 200g, and the health condition of the mice is good; the inventor divides 40 mice into two groups (group one and group two), 20 mice each; the production environments and the culture modes of the two groups are the same; the first group is a reference group, the second group is an experiment group, the first group adopts a common incandescent lamp to irradiate an experiment object, the second group adopts a lamp (such as a bulb or a lamp tube) provided with the light source module 1 to irradiate the experiment object, the parameters of illumination, color temperature and the like of the lamp are the same, and the irradiation time is five continuous days. The specific experimental method and the flow are as follows: firstly, dividing 40 mice into two groups (group one and group two), wherein the group one is continuously irradiated by a common incandescent lamp for five days, and the group two is continuously irradiated by a lamp provided with the light source module 1 for five days; the living environment and the feeding food of the two groups are the same in the experimental process; five days later, 5% chicken red blood cells were intraperitoneally injected into all mice, each of which was 0.2ml; after the injection is finished, the mice are put back to the corresponding original experiment places; two hours later, the mice are killed by adopting a cervical dislocation method (the right hand grabs the mice and pulls the mice backwards with force, meanwhile, the left thumb and the index finger press the heads of the mice downwards with force, the spinal cord and the brain marrow are broken, the mice die immediately), 0.5ml of physiological saline is injected into the abdominal cavity immediately, after the abdominal cavity is gently kneaded for 2 minutes, the abdominal skin is sheared off, a small opening is formed in the muscle layer, abdominal cavity liquid and a clean glass slide are taken to push up a piece, incubation is carried out for 30 minutes at 37 ℃, microscopic examination is carried out after dyeing, statistics is directly observed under a microscope, and the average of 2000 macrophages of each mouse is obtained; and calculating the phagocytic rate and the phagocytic index, wherein the phagocytic rate is calculated. Wherein phagocytic rate = number of macrophages phagocytizing chicken red blood cells/2000 x 100%, phagocytic index = total number of chicken red blood cells phagocytosed/number of macrophages phagocytizing chicken red blood cells. And counting the data of the first group and the second group, and calculating the average number of different groups to obtain a first table.
Table a statistics of the average phagocytosis rate and phagocytosis index for each group of experiments
Group of Phagocytosis rate/% Phagocytosis index
Group I 39.7 0.62
Group II 58.4 0.88
As can be seen from table one, the light source module 1 of the present technical scheme irradiates the mice for a period of time, compared with the irradiation of the mice with the common incandescent lamp, the phagocytosis rate and the phagocytosis index of the macrophages in the abdominal cavity of the mice can be significantly improved, which indicates that the light source module 1 of the present technical scheme can enhance the phagocytosis rate of the macrophages in the abdominal cavity of the experimental mice to the chicken red blood cells, and improve the cellular immunity of the mice. Therefore, the first group of experiments show that the light source module 1 of the technical scheme is used for irradiating organisms, so that the phagocytic rate and the phagocytic index of macrophages can be enhanced, and the immunity of the organisms (including human bodies) can be improved.
Further, the wavelength of the light emitted from the infrared light source 123 is 760nm to 14000nm.
As described above, the wavelength of infrared rays ranges from 760nm to 1mm, that is, from 760nm to 1000000nm. The infrared rays are further classified into near infrared rays, intermediate infrared rays and far infrared rays, wherein the wavelength range of the near infrared rays is about 750nm to 3000nm, the wavelength range of the intermediate infrared rays is about 3000nm to 40000nm, and the wavelength range of the far infrared rays is about 40000 ~ 1000000nm. The wavelength of the light emitted from the infrared light source 123 is 760nm to 14000nm, that is, the infrared light emitted from the infrared light source 123 is mainly near infrared light and mid infrared light. After far infrared rays act on human skin, most of energy is absorbed by the skin, and the absorbed energy is converted into heat energy, so that the temperature of the skin is increased, the blood vessel is dilated and the blood circulation is quickened; the infrared rays can also improve blood circulation and increase phagocytic function of cells. Autonomic nerves mainly regulate visceral functions, and people are in an anxiety state for a long time, and the autonomic nervous system is continuously stressed, so that immunity is reduced, headache, dizziness, insomnia, hypodynamia and cold limbs are caused; the infrared ray can regulate autonomic nerve to maintain optimal state, and the symptoms can be improved or removed. The inventors conducted a second set of experiments regarding the influence of the wavelength range of infrared rays on the effect of improving the immunity of the light source module 1, the main variable of the experiments being the wavelength of the light emitted from the infrared light source 123. The subjects in the second group of experiments were 140 mice weighing about 200g, and the health status of the mice was good. The second group of experiments divided 140 mice into seven groups (group three, group four, group five, group six, group seven, group eight and group nine), 20 each. The survival environment, cultivation mode, feeding food, etc. of the subjects in the second group were the same as those in the first group. Parameters such as illumination and color temperature of the lamp are the same. The experimental mode is that the range values of the infrared wavelengths emitted by the infrared light sources 123 in the lamps used for the seven groups of experiments in the second group are different; the irradiation time was the same as that of the first group, and the experimental method, the detection method and the data statistics method after irradiation were the same as those of the first group. The data obtained for the second set of experiments are shown in Table two.
Table II statistics of average phagocytosis rate and phagocytosis index of each group of experiments
Group of Infrared wavelength/nm Phagocytosis rate/% Phagocytosis index
Group III 760~1000 58.7 0.89
Group IV 1000~3000 59.2 0.91
Group five 3000~6000 59.6 0.95
Group six 6000~10000 60.2 0.98
Group seven 10000~14000 61.3 1.03
Group eight 14000~18000 58.6 0.88
Group nine 18000~24000 58.3 0.87
As can be seen from the comparison analysis of the two data, the light source module 1 has better effect of improving the immunity of the organism when the wavelength of the light emitted by the infrared light source 123 is 760 nm-14000 nm. In the infrared region, the near infrared portion penetrates the tissue to the deepest extent, up to 10 mm, and can directly act on blood vessels, lymphatic vessels, nerve endings and other subcutaneous tissues of the skin. In the infrared region, the most beneficial wave band for human body is 4000 nm-14000 nm, which is called as 'fertility light' in medical field, because the infrared wave band has promoting effect on life growth, the infrared has good effect on activating cell tissue and blood circulation, can improve human immunity and strengthen metabolism of human body.
Further, the light source 12 further includes an ultraviolet light source 124, and the wavelength of the light emitted by the ultraviolet light source 124 is 315nm to 400nm.
The ultraviolet light source 124 is used for emitting ultraviolet light, and the wavelength of the ultraviolet light ranges from 10nm to 400nm. Ultraviolet rays with a wavelength range of 315nm to 400nm are called long-wave ultraviolet rays (UVA), and UVA has the effects of resisting rickets, sterilizing and enhancing immunity. The inventors conducted a third set of experiments as to whether the ultraviolet light source 124 is included in the light source 12 and what wavelength range the ultraviolet light source 124 emits. The experimental subjects of the third group of experiments are 80 mice with the weight of about 200g, and the health condition is good; 80 mice were divided into four groups (ten, eleven, twelve and thirteen), 20 each; the survival environment, cultivation mode, feeding food, etc. of the subjects of the third group were the same as those of the first group. Parameters such as illumination and color temperature of the lamp are the same. The experimental mode of the third group of experiments is that the four groups of experiments are irradiated by different lamps, the lamps used by the four groups all contain ultraviolet light sources 124, but the variable among the four groups is the light wave range of ultraviolet rays emitted by the ultraviolet light sources 124; the irradiation time was the same as that of the first group, and the experimental method, the detection method and the data statistics method after irradiation were the same as those of the first group. The experimental data for group two was counted as a comparative system in the third set of experiments, and thus the data is shown in table three.
Table three third experiment group phagocytosis rate and average value statistics of phagocytosis index
Group of Ultraviolet wavelength/nm Phagocytosis rate/% Phagocytosis index
Group II /(no ultraviolet light source 124) 58.4 0.88
Group ten 10nm~100nm 59.6 0.93
Eleven groups 100nm~280nm 60.3 0.98
Twelve groups 280nm~315nm 60.9 1.03
Group thirteen 315nm~400nm 61.5 1.21
As can be seen from the analysis and comparison of the three data, when the ultraviolet light source 124 is contained in the light source 12 under the same experimental conditions and the same experimental time, the phagocytic rate and the phagocytic index of the mice are higher, and the effect of improving the immunity of organisms is better; therefore, it can be seen that the light source module 1 is more effective for improving the immunity of the human body when the ultraviolet light source 124 is included in the light source 12. On the other hand, compared with the ultraviolet wavelength in other ranges, when the ultraviolet wavelength ranges from 315nm to 400nm, the phagocytic rate and the phagocytic index of the mice are higher, and the effect of improving the organism immunity is better; therefore, the ultraviolet light of the light source 12 has a wavelength ranging from 315nm to 400nm, which is more effective for improving the immunity of the human body.
Further, the spectral power of the ultraviolet light source 124 accounts for 2-6 of the total power of the light source 12.
When the light source 12 includes the lemon light source 121, the red light source 122, the infrared light source 123 and the ultraviolet light source 124, the sum of the spectral power ratios of the four is 100% of the total power of the light source 1212; meaning that the larger the spectral power ratio of one or more of the light sources 12, the smaller the spectral power ratio of the other light sources 12, and thus the determination of the spectral power ratio of one or more of the light sources 12 should take into account the other light sources 12 for better results. The spectral power of the lemon light source 121, the red light source 122 and the infrared light source 123 all account for 30-35% of the total power of the light source 12. The inventors performed a fourth set of experiments on different ratios of the spectral power of the ultraviolet light source 124 to the total power of the light source 12. In the fourth set of experiments, the main variable was the spectral power ratio of the ultraviolet light source 124, and the spectral power ratios of the lemon light source 121, the red light source 122, and the infrared light source 123 were all appropriately adjusted in the range of 30 to 35%. The experimental subjects of the fourth group of experiments are 140 mice with the weight of about 200g, and the health condition is good; the inventors divided 140 mice into 7 groups (fourteen, fifteen, sixteen, seventeen, eighteen, nineteen, twenty) of 20 each. The survival environment, cultivation mode, feeding food, etc. of the subjects in the fourth group were the same as those in the first group. Parameters such as illumination and color temperature of the lamp are the same. Some parameters of the light sources 12 in the fixtures used for the seven groups are shown in the table below.
Table four fourth experiment table for statistics of parameters of light source 12 in each group
Figure GDA0004171556700000091
The irradiation time of the fourth group of experiments is the same as that of the first group, and the experimental method, the detection method, the data statistics method and the like after irradiation are the same as those of the first group. The data obtained for the fourth set of experiments are shown in Table five.
Table five fourth experiment group phagocytosis rate and average value statistics of phagocytosis index
Figure GDA0004171556700000092
Figure GDA0004171556700000101
As can be seen from the experimental data in table four and table five, when the spectral powers of the lemon light source 121, the red light source 122 and the infrared light source 123 all account for 31-33% of the total power of the light source 12, and the spectral power of the ultraviolet light source 124 accounts for 2-6% of the total power of the light source 12, the phagocytic rate and the phagocytic index of the mice are at higher levels, and the light source module 1 has better effect of improving the immunity of the organism.
Further, the spectral power of the lemon light source 121, the red light source 122 and the infrared light source 123 respectively account for 32% of the total power of the light source 12, and the spectral power of the ultraviolet light source 124 accounts for 4% of the total power of the light source 12.
As can be seen from the analysis of the experimental data in table four and table five, the phagocytic rate and phagocytic index of the mice in seventeen groups were higher than those of the other groups; it follows that: when the spectral power of the lemon light source 121, the red light source 122 and the infrared light source 123 respectively account for 32% of the total power of the light source 12 and the spectral power of the ultraviolet light source 124 accounts for 4% of the total power of the light source 12, the light source module 1 has better effect on improving the immunity of organisms.
Further, the illuminance E of the light source 12 is 200LX to 600LX.
Illuminance, i.e., illumination intensity, refers to the luminous flux of visible light received per unit area, in Lux (Lux or LX); an amount indicating the intensity of illumination and the degree to which the surface area of the object is illuminated. The inventors conducted a fifth set of experiments with respect to the influence of the illuminance of the light source 12 on the effect of improving the immunity of the light source module 1. The experimental subjects of the fifth group of experiments are 120 mice with the weight of about 200g, and the health condition is good; the inventors divided 120 mice into 6 groups (twenty-one, twenty-two, twenty-three, twenty-four, twenty-five, twenty-six) of 20 each. In the fifth set of experiments, the parameters of the light source 12 were largely the same among the groups, and the variable was the illuminance of the light source 12. The survival environment, cultivation mode, feeding food, etc. of the subjects in the fifth group were the same as those in the first group. The irradiation time of the fifth group of experiments is the same as that of the first group, and the experimental method, the detection method, the data statistics method and the like after irradiation are the same as those of the first group. The data obtained for the fifth set of experiments are shown in Table six.
Table six fifth experiment group phagocytosis rate and average value of phagocytosis index statistics table
Group of illuminance/LX Phagocytosis rate/% Phagocytosis index
Group twenty-one 100 61.3 1.18
Group twenty-two 200 61.8 1.22
Group twenty-three 400 63.3 1.36
Group twenty-four 600 62.5 1.29
Twenty-five groups 700 61.6 1.20
Group twenty-six 800 61.0 1.13
From the experimental data in table six, it is found that when the illuminance of the light source 12 is between 200LX and 600LX, the phagocytic rate and the phagocytic index of the mice are both higher than the values corresponding to the other range values, that is, the effect of the organism on enhancing the immunity is better when the illuminance of the light source 12 is reflected in the range of values.
Further, the lemon light source 121, the red light source 122, the infrared light source 123 and the ultraviolet light source 124 are uniformly distributed around the center of the substrate 11, respectively;
the lemon light source 121 and the ultraviolet light source 124 are disposed at intervals, and the red light source 122 and the infrared light source 123 are disposed at intervals.
The lemon light source 121, the red light source 122, the infrared light source 123 and the ultraviolet light source 124 are uniformly distributed around the center of the substrate 11, that is, the distances from the four light sources to the center of the substrate 11 are equal, and the distances between two adjacent light sources 12 in the four light sources are also equal. The main purpose of this arrangement is to mix the light emitted from the lemon light source 121, the red light source 122, the infrared light source 123 and the ultraviolet light source 124 more uniformly, so that the light source module 1 has better effect of improving immunity. In the inventive process, the inventors performed a sixth set of experiments with respect to the arrangement of the lemon light source 121, the red light source 122, the infrared light source 123, and the ultraviolet light source 124. The sixth set of experiments was provided with four arrangements: the first arrangement is that the lemon light source 121, the red light source 122, the infrared light source 123 and the ultraviolet light source 124 are respectively and uniformly distributed around the center of the substrate 11 in sequence; the second arrangement mode is that the lemon light source 121, the red light source 122, the infrared light source 123 and the ultraviolet light source 124 are sequentially arranged in the same direction; the third arrangement mode is that the lemon light source 121, the red light source 122, the infrared light source 123 and the ultraviolet light source 124 are enclosed to be rectangular; the fourth arrangement is that the lemon light source 121, the red light source 122, the infrared light source 123 and the ultraviolet light source 124 are uniformly distributed around the center of the substrate 11, and the lemon light source 121 and the ultraviolet light source 124 are arranged at intervals, and the red light source 122 and the infrared light source 123 are arranged at intervals. The experiment object of the sixth group of experiments is 80 mice with the weight of about 200g, and the health condition is good; the inventors divided 80 mice into four groups (twenty-seven groups, twenty-eight groups, twenty-nine groups, thirty-nine groups) of 20 each. The four groups respectively correspond to the light source modules 1 with four different light source 12 arrangement modes. The survival environment, cultivation mode, feeding food, etc. of the subjects in the sixth group were the same as those in the first group. Parameters such as illumination and color temperature of the lamp are the same. The irradiation time of the sixth group of experiments is the same as that of the first group, and the experimental method, the detection method, the data statistics method and the like after irradiation are the same as those of the first group. The data obtained for the sixth set of experiments are shown in Table seven.
Table seven table six experiments groups of phagocytic rates and average values of phagocytic indices statistics
Group of Arrangement mode Phagocytosis rate/% Phagocytosis index
Twenty-seven groups First kind 63.6 1.37
Group twenty-eight Second kind 62.1 1.29
Group twenty-nine Third kind 62.8 1.33
Group of thirty Fourth kind 64.3 1.45
As can be seen from the experimental data of the seventh comparison analysis table, compared with the lemon light source 121, the red light source 122, the infrared light source 123 and the ultraviolet light source 124 which are sequentially arranged or enclosed in a rectangle along the same direction, the four are uniformly distributed around the center of the substrate 11 respectively, so that the phagocytic rate and the phagocytic index of the mice can be improved, i.e. the immunity effect for improving organisms is better; as can be seen from the experimental data of twenty-seven groups and thirty-seven groups, when the lemon light source 121 and the ultraviolet light source 124 are arranged at intervals and the red light source 122 and the infrared light source 123 are arranged at intervals, the phagocytosis rate and the phagocytosis index of the mice are higher than those of the lemon light source 121, the red light source 122, the infrared light source 123 and the ultraviolet light source 124 which are respectively and uniformly distributed around the center of the substrate 11 in sequence, and the main reason is that the red light source 122 and the infrared light source 123 with relatively close wavelengths are spaced apart, so that the light rays emitted by the light source 12 are uniformly mixed, and the effect of the light source module 1 on improving the immunity of organisms is better.
Further, the substrate 11 is circular, and the plurality of lemon light sources 121 are uniformly arranged along the same diameter direction of the substrate 11; the plurality of red light sources 122 are uniformly arranged along the same diameter direction of the substrate 11; the plurality of infrared light sources 123 are uniformly arranged along the same diameter direction of the substrate 11; the plurality of ultraviolet light sources 124 are uniformly arranged along the same diameter direction of the substrate 11.
The shape of the substrate 11 is in a circular shape, and the lemon light source 121, the red light source 122, the ultraviolet light source 124 and the infrared light source 123 are respectively and uniformly distributed around the center of the substrate 11 in sequence; the fourth can be in the form of a lamp bead. The lemon light source 121, the red light source 122, the ultraviolet light source 124 and the infrared light source 123 are all provided in plurality and the same number; the plurality of lemon light sources 121 are uniformly arranged on the same diameter of the substrate 11, the plurality of red light sources 122 are uniformly arranged on the same diameter of the substrate 11, the plurality of ultraviolet light sources 124 are uniformly arranged on the same diameter of the substrate 11, the plurality of infrared light sources 123 are uniformly arranged on the same diameter of the substrate 11, the lemon light sources 121 and the ultraviolet light sources 124 are positioned on the same diameter of the substrate 11, and the red light sources 122 and the infrared light sources 123 are positioned on the same diameter of the substrate 11. In the inventive process, the inventors performed a seventh set of experiments with respect to the number of the lemon light source 121, the red light source 122, the infrared light source 123, and the ultraviolet light source 124 disposed on the substrate 11. The seventh group of experiments has 60 mice with weight of about 200g and good health condition; the inventors divided 60 mice into three groups (thirty-one, thirty-two, thirty-three) of 20 each. In the experiment, data of thirty groups are used as comparison data to be statistically compared together; the number of lemon light sources 121, red light sources 122, infrared light sources 123, and ultraviolet light sources 124 in the different groups is specified in table eight below.
Table eight statistics of the number of various light sources 12 in each of the seventh experiment groups
Figure GDA0004171556700000131
The survival environment, cultivation mode, feeding food, etc. of the seventh group of subjects were the same as those of the first group of experiments. The irradiation time of the seventh experiment is the same as that of the first experiment, and the experimental method, the detection method, the data statistics method and the like after irradiation are the same as those of the first experiment. The data obtained for the seventh set of experiments are shown in Table nine.
Table nine seventh experiment group phagocytosis rate and average value statistics of phagocytosis index
Group of Phagocytosis rate/% Phagocytosis index
Group of thirty 64.3 1.45
Group thirty one 64.8 1.52
Group thirty-two 65.4 1.59
Group thirty-three 66.3 1.65
As can be seen from comparing the data in table eight and table nine, the greater the numbers of the lemon light source 121, the red light source 122, the infrared light source 123 and the ultraviolet light source 124 in the light source module 1, the higher the phagocytic rate and the phagocytic index of the mice, i.e. the better the immunity effect for improving the organism.
In another aspect of the present invention, a lighting device capable of improving immunity of a human body includes a lamp body 2 and a light source module 1 as described above, wherein the light source module 1 is installed in the lamp body 2. The light source module 1 is used as a light emitting element capable of improving human immunity and is arranged in the lamp main body 2 to form a complete lighting device, so that the lighting device is convenient to use.
Example two
As shown in fig. 2 to 6, the lamp body 2 includes a first heat sink 21 and a first lamp cover 22, the first heat sink 21 and the first lamp cover 22 are encapsulated to form a lamp cavity 25, the light source module 1 is mounted on the first heat sink 21, and the light source module 1 is located inside the lamp cavity 25.
The first radiator 21 and the first lampshade 22 are assembled together to form a long cylindrical shape, specifically, the assembled part of the first radiator 21 and the first lampshade 22 is semi-cylindrical, and after the two parts are packaged, a hollow cylindrical shape is formed, and the hollow part is the lamp tube cavity 25. The light source module 1 is arranged on the first radiator 21 and is positioned above the first lampshade 22, and the light source module 1 is arranged on the first radiator 21; when the lamp tube works, the light source module 1 can emit light for improving immunity, and the light source module 1 can generate heat in the lamp tube work, so that the light source module 1 is arranged on the first radiator 21, heat can be timely dissipated, and damage to components caused by overhigh temperature is avoided. The first lamp housing 22 and the first heat sink 21 form a closed lamp cavity 25, thereby protecting the light source module 1 disposed in the lamp cavity 25.
Further, the lamp body 2 further comprises a lamp pin 23 and a lamp plug 24, the lamp plug 24 is installed at two ends of the lamp cavity 25, and the lamp pin 23 is installed on the lamp plug 24.
Two lamp plugs 24 are respectively installed at both ends of the first radiator 21 and the first lamp shade 22 to form a closed lamp cavity 25; the lamp pin 23 is mounted on the lamp plug 24, and the lamp pin 23 is mainly used for connecting the light source module 1 with an external power supply. As is well known, a general lamp needs to be installed on a corresponding lamp holder when in use, and the lamp is connected with the lamp holder through a lamp plug and a lamp pin at two ends of the lamp. The lighting device of this embodiment is in the form of a lamp tube, and is also provided with a lamp tube plug 24 and a lamp needle 23, so that the lighting device is conveniently mounted on a lamp holder.
Further, the first radiator 21 includes a first arched portion 211, a second arched portion 213, and a vertical portion 212 connecting the first arched portion 211 and the second arched portion 213, and the cross section of the first radiator 21 is approximately i-shaped; the first lampshade 22 is semi-cylindrical, and the side edges of the two sides of the first lampshade are clamped and/or bonded with the side edges of the two sides of the first arched portion 211.
The cross section of the first radiator 21 is approximately in an i shape, and is sequentially provided with a second arched portion 213, a vertical portion 212 and a first arched portion 211 from top to bottom. The first radiator 21 is located above the first lampshade 22, and the two radiator packages form a lamp body, specifically, the side edges of the two sides of the first arch part 211 are clamped and/or bonded together with the side edges of the two sides of the first lampshade 22. Taking the first arch portion 211 and the first lampshade 22 as an example, specifically, grooves 2111 may be formed on two sides of the first arch portion 211, raised strips 221 may be formed on two sides of the first lampshade 22, and then the raised strips 221 may be clamped in the grooves 2111; specifically, the tail end of the first lamp shade 22 is inserted from the head end of the first radiator 21, so that the tail ends of the convex strips 221 are inserted into the head end of the groove 2111, and then the first lamp shade 22 is pushed, and when the head end of the first lamp shade 22 coincides with the head end of the first radiator 21 and the tail end of the first lamp shade 22 coincides with the tail end of the first radiator 21, the packaging of the two is completed. Of course, the connection between the first arch portion 211 and the first lampshade 22 may be adhesive, or one-side clamping and one-side adhesive. The first radiator 21 is shaped to facilitate connection with the first lamp housing 22.
The second arched portion 213 has the same radius as the cross section of the first lamp housing 22, so that the cross section of the lamp body main body is a perfect circle. So the structure of the lamp tube main body is more reasonable and beautiful.
Example III
As shown in fig. 7 to 8, the lamp body 2 includes a second lamp cover 26, a housing 27, a screw housing 28, a negative ion generator 29, a driver 201, and a power contact 202; second lamp housing 26 and threaded housing 28 are mounted at both ends of housing 27, respectively; the light source module 1 is arranged in the second lampshade 26, and the light source is positioned at one end close to the second lampshade 26; the power contact 202 is mounted on the threaded housing 28 and electrically connected to the light source and the driver 201; the negative ion generator 29 and the driver 201 are both installed in the housing 27, and the driver 201 is electrically connected with the negative ion generator 29; the side wall of the housing 27 is provided with ventilation holes 271.
Specifically, the lighting device of the present embodiment is in the form of a bulb. The second lampshade 26 and the threaded shell 28 are respectively arranged at two ends of the shell 27, the light source module 1 is arranged in a cavity formed by the second lampshade 26 and the shell 27 after being assembled, and a light source on the light source module 1 faces the second lampshade 26, so that light rays emitted by the light source can be emitted outwards through the second lampshade 26 and further irradiate a human body; the outer wall of the threaded shell 28 is provided with threads for mating with an external lamp socket to which the bulb is mounted, in particular the threaded shell 28 is screwed. The screw housing 27 is provided with a power contact 202, the power contact 202 is electrically connected with the light source and the driver 201, when the bulb is mounted on the lamp holder, an external power is transmitted to the power contact 202 through the lamp holder, and then the power contact 202 transmits the power to the light source module 1 and the driver 201. The driver 201 is electrically connected with the negative ion generator 29, and both are located in the housing 27, and the driver 201 can drive the negative ion generator 29 to operate after being electrified, and the negative ion generator 29 has the functions of refreshing air, eliminating smoke and dust, enhancing the moisture retention of hair and preventing hair from being split. The side wall of the housing 27 is provided with a vent hole 271 penetrating the inside of the housing 27 and the outside of the housing 27, and air can circulate between the outside and the inside of the housing 27 through the vent hole 271, so that the effect of the negative ion generator 29 is more remarkable.
Example IV
As shown in fig. 9 to 10, the lamp body 2 includes a second heat sink 203, an outer ring 204, an inner ring 205, an optical plate 206, a rubber ring 207, and a torsion spring 208; the inner ring 205 is sleeved on the second radiator 203, specifically, the rubber ring 207 is sleeved on the inner ring 205 and abuts against the inner wall of the inner ring 205; the outer ring 204 is sleeved on the inner ring 205, and two torsion springs 208 are symmetrically arranged on the inner wall of the outer ring 204; an optical plate 206 is installed at the lower end of the second heat sink 203; the light source module 1 is installed on the second radiator 203, and the light source faces to the side where the optical plate 206 is located; the optical plate 206 is a diffusion plate or a glass sheet.
The lighting device in this embodiment is in the form of a down lamp, the second radiator 203 is hollow, and the lower end is open; an optical plate 206 is mounted on the lower end of the second heat sink 203 to seal the lower end opening. Specifically, the optical plate 206 is sleeved on the second heat sink 203 through the inner ring 205, and then the inner ring 205 fixes the optical plate 206 at the lower end of the second heat sink 203. The light source module 1 is specifically installed on the inner top surface of the second radiator 203, and the light source faces the optical plate 206, and the illumination emitted by the light source is emitted outwards through the optical plate 206. The rubber ring 207 is sleeved on the second radiator 203, and then the inner ring 205 is sleeved on the rubber ring 207, so that the rubber ring 207 is abutted against the inner wall of the inner ring 205, and the inner ring 205 and the second radiator 203 are fixed in an extrusion mode. The outer ring 204 is sleeved on the inner ring 205, two torsion springs 208 are symmetrically arranged on the outer wall of the outer ring 204, and the lamp can be simply and directly embedded and installed on the corresponding position by utilizing the elasticity of the torsion springs 208.
The foregoing description is only of the preferred embodiments of the present invention and is not intended to limit the scope of the invention, and all equivalent structural changes made by the description of the present invention and the accompanying drawings or direct/indirect application in other related technical fields are included in the scope of the invention.

Claims (7)

1. A light source module capable of improving human immunity is characterized in that: the LED lamp comprises a substrate and a light source arranged on the substrate, wherein the light source comprises a lemon light source, a red light source, an infrared light source and an ultraviolet light source;
the wavelength of the light emitted by the lemon light source is 567 nm-587 nm; the wavelength of the light emitted by the red light source is 620 nm-700 nm; the wavelength of the light emitted by the infrared light source is 760 nm-1 mm, and the wavelength of the light emitted by the ultraviolet light source is 315 nm-400 nm;
the spectrum power of the lemon light source, the spectrum power of the red light source and the spectrum power of the infrared light source respectively account for 32% of the total power of the light sources, and the spectrum power of the ultraviolet light source accounts for 4% of the total power of the light sources.
2. The light source module for improving immunity of human body according to claim 1, wherein: the wavelength of the light emitted by the infrared light source is 760 nm-14000 nm.
3. The light source module for improving immunity of human body according to claim 1, wherein: the illuminance E of the light source is 200 LX-600 LX.
4. The light source module for improving immunity of human body according to claim 2, wherein: the lemon light source, the red light source, the infrared light source and the ultraviolet light source are respectively and uniformly distributed around the center of the substrate;
the lemon light source and the ultraviolet light source are arranged at intervals, and the red light source and the infrared light source are arranged at intervals.
5. The light source module for improving immunity of human body according to claim 4, wherein: the substrate is circular, and the plurality of lemon light sources are uniformly distributed along the same diameter direction of the substrate; the plurality of red light sources are uniformly distributed along the same diameter direction of the substrate; the plurality of infrared light sources are uniformly distributed along the same diameter direction of the substrate; the plurality of ultraviolet light sources are uniformly distributed along the same diameter direction of the substrate.
6. A lighting device for improving immunity of a human body, comprising a lamp body and the light source module according to any one of claims 1 to 3, wherein the light source module is installed in the lamp body.
7. A lighting device for improving immunity of a human body as recited in claim 6, wherein: the lamp body comprises a first radiator and a first lampshade, wherein the first radiator and the first lampshade are packaged to form a lamp tube cavity, the light source module is installed on the first radiator, and the light source module is located inside the lamp tube cavity.
CN202010843806.2A 2020-08-20 2020-08-20 Light source module capable of improving immunity of human body and lighting device Active CN114076266B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202010843806.2A CN114076266B (en) 2020-08-20 2020-08-20 Light source module capable of improving immunity of human body and lighting device

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202010843806.2A CN114076266B (en) 2020-08-20 2020-08-20 Light source module capable of improving immunity of human body and lighting device

Publications (2)

Publication Number Publication Date
CN114076266A CN114076266A (en) 2022-02-22
CN114076266B true CN114076266B (en) 2023-05-23

Family

ID=80281849

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202010843806.2A Active CN114076266B (en) 2020-08-20 2020-08-20 Light source module capable of improving immunity of human body and lighting device

Country Status (1)

Country Link
CN (1) CN114076266B (en)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2961478A4 (en) * 2013-03-01 2017-01-11 Klox Technologies Inc. Phototherapeutic device, method and use
NZ767766A (en) * 2014-09-09 2023-03-31 Lumithera Inc Multi-wavelength phototherapy devices, systems, and methods for the non-invasive treatment of damaged or diseased tissue
CN206822961U (en) * 2017-01-18 2018-01-02 深圳市红果智能科技有限公司 Portable multi-function physiotherapy beautifying instrument
CN107469235A (en) * 2017-09-05 2017-12-15 武汉中科科理光电技术有限公司 Multifunctional spectrum treatment system and therapeutic equipment

Also Published As

Publication number Publication date
CN114076266A (en) 2022-02-22

Similar Documents

Publication Publication Date Title
CN203525150U (en) Photon therapeutic instrument
CN101922642A (en) Multi-functional high-power LED lamp
CN201441754U (en) Neonatal jaundice phototherapy blanket
TWM300116U (en) Laser wrinkle removing device
CN114076266B (en) Light source module capable of improving immunity of human body and lighting device
CN201710824U (en) Phototherapy type skin care device
TWM630768U (en) Lighting device with phototherapy effect
CN201328925Y (en) Visual phototherapy instrument
KR20160045856A (en) Diffusion pigments in phototherapy
CN202136695U (en) Novel infrared ray negative oxygen ion generating device
CN204502157U (en) A kind of Novel head cover
KR102117262B1 (en) Diagnosis and treatment apparatus of skin using color light
KR102421365B1 (en) Mask device for facial skin care that emits far-infrared rays
CN108404296A (en) A kind of combined light source device
RU83700U1 (en) ANATOMIC CORRECTIVE TREATMENT-PREVENTIVE AMILY DEVICE
CN210131260U (en) Low-intensity laser repair whole-body phototherapy instrument
CN114344731A (en) Vision maintenance method and equipment based on retina ATP light wave energy supplementing technology
CN113970077B (en) Lighting module capable of improving sleep and lamp
CN203154620U (en) Hair growth nursing instrument
CN112972906A (en) Multifunctional LED beauty and health lamp based on red, yellow and blue wavelength gain
CN203598371U (en) Red light, rock salt and far-infrared ray combined phototherapeutic and physiotherapeutic device
CN207679874U (en) A kind of novel smooth power physical therapy mask
CN206205509U (en) Optical wave house with transparent jade
CN104208820B (en) Single-point type anti-acne device
RU155992U1 (en) THERAPEUTIC LAMP

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant